Why a CT scan and not an MRI? Do I need another cardiac echo? Diagnostic tests for cardiovascular patients

Because of its reliability, sensitivity and low cost, PCR has become the backbone of modern diagnostics. In recent years, researchers have ingeniously capitalized on the fundamental nature of PCR through multiplexing reactions saving reagent costs, precious samples, and user time. Multiplexing has also enabled pathogen screening and genotyping for much larger numbers of targets, thereby improving the breadth and utility of diagnostics. However, while multiplexing reactions can be a boon to lab productivity, they are not without their pitfalls.

What is DNA and how can learning about yours help you to build your family tree? Discover the ins and outs of DNA including: Components and Types of DNA, How DNA replicates itself, Mutations, Genes and Chromosomes, Dominant and Recessive genes, Sex-linked genes, Hereditary Diseases, Inheritance of blood types.

As scientific innovation has led to new trial designs, modern cloud technologies have enabled the industry to better manage how clinical trials are executed. Newer, more advanced cloud applications now offer unified data and process models, allowing organizations to manage their end-to-end clinical trial process within a single system. Rather than juggling individual point solutions, innovative organizations are using a unified clinical platform for greater efficiency, quality, and speed of execution. Join Veeva and Idorsia to learn how your organization can leverage a unified clinical operating model and drive new levels of efficiency across the entire clinical ecosystem.

Mammalian cell line generation is a rate-limiting step in early CMC development and there is a constant desire to increase throughput. The implementation of automation is one way to increase throughput. This webinar will address some factors to consider during the process of automating a manual workflow including details of culture vessel changes, liquid handling adaptation, and changes of the cell line developer’s job during the process. With an end result of increased throughput, automation potentially allows cell line development to begin prior to final molecule selection. This can remove cell line development off the critical path of CMC development.